ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Güden, M.
Right arrow Articles by Bayindir, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Güden, M.
Right arrow Articles by Bayindir, O.
Related Collections
Right arrow Electrophysiology - arrhythmias

Ann Thorac Surg 2002;74:S1301-S1306
© 2002 The Society of Thoracic Surgeons


Supplement: Cardiothoracic Techniques and Technologies

Intraoperative saline-irrigated radiofrequency modified Maze procedure for atrial fibrillation

Mustafa Güden, MDa, Belhhan Akpinar, MDa*, Ilhan Sanisoglu, MDa, Ertan Sagbas, MDa, Osman Bayindir, MDb

a Department of Cardiovascular Surgery, Florence Nightingale Hospital, Istanbul, Turkey
b Department of Anesthesia, Kadir Has University, Florence Nightingale Hospital, Istanbul, Turkey

* Address reprint requests to Dr Akpinar, Florence Nightingale Hospital, Abide’i HÜrriyet Cad. No:290, 80220 S I SLI, Istanbul, Turkey
e-mail: belh{at}turk.net

Presented at the Eighth Annual Cardiothoracic Techniques and Technologies Meeting 2002, Miami Beach, FL, Jan 23–26, 2002.


    Abstract
 Top
 Abstract
 Introduction
 Material and method
 Results
 Comment
 References
 
BACKGROUND: This study was conducted to evaluate the effectiveness of the saline-irrigated radiofrequency modified Maze operation for treatment of chronic atrial fibrillation, and to compare the results of the left and biatrial procedures.

METHODS: During a period of 11 months, 62 patients with chronic atrial fibrillation who were having concomitant cardiac surgery underwent the procedure. The mean age of the patients was 52 ± 14 years. Patients underwent either a biatrial (group A; n = 39) or left atrial (group B; n = 23) procedure.

RESULTS: Two patients (3.2%) died early in the postoperative period. Three patients (4.8%) required reoperation for bleeding. One patient in group A (1.6%) received a permanent pacemaker. Patients in both groups were free of atrial fibrillation at the end of the procedure (group A: sinus 86.9%, pacemaker 13%; group B: sinus 90.5%, pacemaker 9.5%) (p > 0.05). At 1-month and longer-term follow-up, sinus rhythm was maintained in 92% and 95% of cases in group A, respectively, whereas this rate was 71% and 81% in group B (p > 0.05). Holter monitor surveillance revealed a higher rate of atrial fibrillation, atrial arrhythmias, and atrial flutter in group B (p < 0.05). Transthoracic echocardiography revealed improvement over time in left atrial transport function in both groups (p < 0.05).

CONCLUSIONS: The saline-irrigated radiofrequency modified Maze procedure was performed safely and efficiently. Both the left and biatrial procedures were successful in terms of restoring sinus rhythm during short-term follow-up. Long-term follow-up with more cases is needed to show the superiority of one method over the other.


    Introduction
 Top
 Abstract
 Introduction
 Material and method
 Results
 Comment
 References
 

Dr Akpinar discloses that he has a financial relationship with Medtronic, Inc.

 

Atrial fibrillation (AF) is a common arrhythmia that affects 0.4% of the general population and up to 10% of persons older than 65 years of age. More importantly, 60% of patients admitted for mitral valve surgery and up to 5% of patients undergoing coronary revascularisation are known to have chronic AF [1]. The Maze III procedure, described by Cox and colleagues [2], remains the gold standard for the surgical treatment of AF. The Maze III procedure is highly effective; however, it is an extensive and time-consuming technique, which precludes its widespread application. In an effort to reduce technical concerns with the procedure, a variety of other sources such as cryoablation, microwave, bipolar cautery, and radiofrequency (RF) have been used to create lesions similar to those used in the original "cut and sew" technique. Sie and colleagues [3] and Khargi and associates [4] were among the first to use the irrigated RF device to create lesions similar to those in the Maze III procedure, and they named it the "irrigated radiofrequency modified Maze procedure."

The aim of this study was to evaluate the effectiveness of this Saline-Irrigated RF System (Cardioblate, Medtronic Inc, Minneapolis, MN) for surgical treatment of AF, and to determine whether performing left-sided lesions alone would be as effective as performing the biatrial Maze procedure in eradicating AF.


    Material and method
 Top
 Abstract
 Introduction
 Material and method
 Results
 Comment
 References
 
The Ethical Committee of the hospital approved the study, and informed consent was obtained from each patient. Data were prospectively collected from patients who were having concurrent open heart surgery with AF to undergo the procedure. Throughout this article, the technique used will be referred to as the "saline-irrigated radiofrequency modified Maze" (SIRFMM). Patients with at least 6 months of persistent AF were included in the study. Between February 2001 and December 2001, a total of 62 patients who met these criteria underwent the SIRFMM procedure. Both groups were comparable in terms of sex (group A: 73.7% female, group B: 52.4% female), age (group A: 50 ± 12.9, group B: 53 ± 14), mitral valve pathologic condition (group A: 51% rheumatic, group B: 43% rheumatic), and left ventrical function (group A: EF 50% ± 10%, group B: EF 52% ± 10%).

The RF ablation system
The system consists of a power generator and a pen. The Medtronic Cardioblate surgical ablation pen is a hand-held, unipolar RF ablation device. The electrode tip is irrigated with saline that cools the tissue and provides a low-impedance path, which allows creation of deeper lesions with less damage to the surrounding tissue. Saline irrigation through nine tip openings conducts RF current away from the tip, creating a virtual electrode. The tip of the pen is slowly oscillated over the endocardial tissue during the procedure. The power generator can produce a power output ranging between 20 and 30 W, and a pump achieves irrigation (5 mL/min). The exact duration of application for each lesion varies according to tissue thickness, power setting, and irrigation rate. Higher power settings lead to increased generation of heat, allowing more rapid creation of deeper lesions. However, heating that is too rapid will result in boiling of intracellular fluid, which can cause damage to the tissue and create a so-called "tissue pop." Most of these pops are minor and do not require intervention, but larger pops may require suturing. We observed two cases of tissue pops in our experience, in which the left atrial tissue was repaired with 4-0 Prolene (Ethicon, Somerville, NJ) stitches. Throughout our experience, we used 25 W with an irrigation rate of 5 mL/min.

Surgical technique
After median sternotomy, cardiopulmonary bypass (CPB) was established in a standard fashion. Both vena cavae were cannulated for venous return. Antegrade and retrograde tepid (32°C) blood cardioplegia was used for myocardial protection.

Left-sided SIRFMM
After cardioplegic arrest, left atrial incision was performed through the interatrial groove. Both cavae were encircled with tapes for total CPB to have a dry field during ablation. A larger sling was used to go around the inferior vena cava; by using this sling, the heart was lifted and turned toward the surgeon to facilitate better exposure of the left atrial appendage (LAA). The LAA was either amputated and sutured afterward, or a circumferential radiofrequency lesion was created around its base and the orifice oversewn from inside the atrium. After the LAA was excised, an ablation line from the LAA to the left superior pulmonary vein was created. In addition to the incision in the interatrial groove, isolation of the right pulmonary veins was completed by a circular ablation line. The left pulmonary veins were encircled and a connecting line was performed between both islands of pulmonary veins, as near to the left atrial roof as possible to avoid injury to esophagus. An ablation line from the left pulmonary veins to the posterior mitral annulus was then performed with caution so as not to injure the circumflex coronary artery. Manipulation with the surgeon’s left index finger or administration of retrograde cardioplegia enabled the surgeon to locate the circumflex artery and to prevent injury during the procedure. In some cases, after placement of a surgical instrument in the coronary sinus from the right side to push up against the left atrial wall to locate where the coronary sinus ended on the left side, an ablation line from the middle of the mitral valve ablation line down toward the base of the atria was performed to prevent the reentry pathways moving between the atria through the coronary sinus (Fig 1). After the left-sided Maze procedure, the LAA amputation site was sutured with a horizontal matrix suture technique using pericardial strip for reinforcement. Concomitant procedures were performed only after completing the left-sided ablation. The left-sided Maze procedure added 9 to 12 minutes to the original operation.



View larger version (33K):
[in this window]
[in a new window]
 
Fig 1. Ablation lines performed in the left atrium. Dotted lines indicate radiofrequency ablation lines performed in the left atrium. (See text for detailed explanation.) a= excised and sutured left atrial appendage;b= radiofrequency ablation line performed in areas corresponding to end point of coronary sinus on left atrial side;LPVs= left superior pulmonary veins;RPVs= right superior pulmonary veins.

 
Right-sided SIRFMM
The right-sided procedure was performed during rewarming on partial bypass after removal of the crossclamp. After snaring both caval cannulas, the right atrial appendage (RAA) was excised and an incision (4 cm) was made anteriorly from the amputated RAA toward the inferior vena cavae. A second posterior longitudinal and lateral incision was made at the dorsolateral aspect of the right atrium and extended to the AV groove reaching the interatrial septum. Between the superior and inferior caval cannulation sites, the endocardial surface was ablated (Fig 2). Additional RF ablation lines were made from the excised RAA to the anterior tricuspid leaflet and from the caudal end of the posterior longitudinal incision at the atrioventricular groove to the posterior portion of the annulus of the tricuspid valve. The right-sided procedure was completed with an ablation line performed on the right side of the interatrial septum, starting from the middle of the right atriotomy across the fossa ovalis up to the caudal aspect of the coronary sinus, followed by an ablation line from this point to the inferior vena cava and up to the posterior annulus of the tricuspid valve (Fig 3). After completion of ablation, the right atrial incisions were closed using 4-0 Prolene. The right-sided Maze added 6 to 9 minutes to the original procedure.



View larger version (22K):
[in this window]
[in a new window]
 
Fig 2. Right-sided IRF Maze procedure.a=the right atrial appendage is excised.b= a 4-cm vertical incision toward the vena cava is made.c= a second posterior-longitudinal incision is made in the right atrium.d= an ablation line is created within the right atrium between the superior and inferior caval cannulation sites.

 


View larger version (22K):
[in this window]
[in a new window]
 
Fig 3. Ablation lines in the right atrium. Dotted lines indicate radiofrequency ablation lines performed in right atrium. (See text for detailed explanation.)a= The excised right atrial appendage is sutured.CS= coronary sinus;FO= fossa ovalis;TV= tricuspid valve.

 
Modifications and technical details
In 6 patients with previous closed mitral commissurotomy and in 3 patients with a thin fragile tissue, the LAA was not amputated. Instead, a circumferential radiofrequency lesion around the base of the LAA within the left atrium was performed, followed by oversewing of the orifice. The rest of the ablation procedure was the same as the left-sided Maze procedure described above. All patients underwent anatomic and electrophysiologic exclusion of the LAA by one means or another. The advantage of excluding the LAA anatomically is the likelihood of a lower incidence of stroke. In patients whom the LAA was amputated, closure of the suture line was performed only after the completion of left-sided Maze procedure to avoid any damage to the suture line by the RF heat waves. The transesophageal echocardiographic probe was removed during the ablation to prevent any damage by the transmission of the heat waves to the esophagus. Manipulation by the the surgeon’s index finger or administration of retrograde cardioplegia was useful to locate the coronary artery and to avoid damage to the circumflex artery while performing the ablation line toward the mitral annulus.

Decision to perform left or biatrial procedure
The biatrial Maze procedure was applied in cases in which the right atrium had to be opened for a tricuspid valve inspection or an atrial septal defect, or if the patient formerly had an atrial flutter. Otherwise, the procedure was limited to the left side. We had two subgroups of patients: group A (n = 39) consisted of patients who underwent both the left and right-sided Maze procedure, whereas group B (n = 23) comprised patients who underwent only the left-sided Maze procedure.

Follow-up for the whole group ranged from 45 to 245 days (mean 104 days). All patients underwent 24 hours of Holter monitoring during their hospitalization. Atrial transport function was evaluated by transthoracic echocardiography at 1 and 6 months postoperatively.

Statistical analysis
Statistical analysis was performed using the Prisma program package, version 3 (BMDP, CA). Fisher’s exact test was used to evaluate differences in the patient groups. McNemar’s test was used to evaluate changes in a variable over time, and the unpaired t test was used for age comparison between two groups. A value of p less than 0.05 was considered to be statistically significant.


    Results
 Top
 Abstract
 Introduction
 Material and method
 Results
 Comment
 References
 
Table 1 shows data on the concomitant surgical procedures. Two patients died during hospitalization (3.2%). Neither of the deaths could be attributed to the ablation procedureboth patients died of multiorgan failure triggered by a pulmonary infection. During late follow-up, 1 patient (2.6%) in group A and 1 patient (4.3%) in group B died. The death of the first patient was accepted as a sudden cardiac death, whereas the death of the second was unexplained.


View this table:
[in this window]
[in a new window]
 
Table 1. Concomitant Surgical Procedures

 
In group A, intraoperative freedom from AF was 100%. Two patients in this group required reoperation for bleeding, which was associated with the LAA amputation site in both cases. One patient in group A received a permanent pacemaker for complete atrioventricular block.

In group B, intraoperatively freedom from AF was also 100%. Six hours after the operation, 1 patient in this group urgently required reopening in the intensive care unit for sudden massive bleeding, which was due to partial disruption of the LAA suture line. The LAA amputation site was repaired and the patient recovered uneventfully.

Table 2 gives the rhythm status of patients during follow-up. Table 3 shows the Holter monitoring and atrial transport function.


View this table:
[in this window]
[in a new window]
 
Table 2. Rhythm Status of Patients

 

View this table:
[in this window]
[in a new window]
 
Table 3. Evaluation of Holter Monitoring in Time and Atrial Transport Function

 
At discharge, at 1 month, and at later control points (45 to 245 days), more patients were free of AF in group A than in group B, although this was not statistically significant (p > 0.05). Holter monitoring revealed more episodes of atrial arrhythmias, AF, and atrial flutter (AFL) in group B (p < 0.05).

Atrial transport function was evaluated at 1 month (n = 59) and 6 months (n = 24) postoperatively using transthoracic echocardiography with Doppler analysis of mitral and tricuspid flows. There was no difference in right atrial transport function between groups A and B at 1 and 6 months postoperatively (p > 0.05) However, left atrial transport function improved over time in both groups (p < 0.05) (Table 3).

At the end of 1 month, the New York Heart Association functional class of patients in both groups had significantly improved (group A: 3.2 ± 0.6/1.8 ± 0.4; group B: 2.8 ± 0.5/2.0 ± 0.7; p < 0.05).

Postoperative considerations
The anticoagulation management protocol was the same as that applied for routine open heart surgery. Patients receiving mechanical valves continued to be treated with Coumadin (Du Pont Pharmaceuticals, Wilmington, DE). For patients who remained in sinus rhythm, the INR was kept around 2 for aortic valves and between 2.5 and 3 for mitral valves. Temporary pacing wires (atrial and ventricular) were routinely used for pacing or for overdriving the atrium when necessary.

As early postoperative arrhythmias may be caused my mechanisms other than chronic AF, patients were given 200 mg/d amiodarone on a routine basis for a period of three months. We do not favor early cardioversion for patients in postoperative AF and reserve this for patients who are still in AF after 3 months. Two patients in group B who were in AF 3 months postoperatively underwent cardioversion, but 1 patient remained in AF despite cardioversion. This patient continued to receive amiodarone.


    Comment
 Top
 Abstract
 Introduction
 Material and method
 Results
 Comment
 References
 
Many procedures have been developed since the early 1980s for surgical treatment of AF. Guiradon [5] was the first to describe a surgical technique designed to treat AF. He created a corridor between the sinus and AV nodes that restored regular rhythm. However, success with the corridor operation was limited by loss of atrial transport function, as the majority of atrial muscle was still fibrillating. The Maze procedure, described by Cox and colleagues [2], not only restored sinus rhythm but also maintained atrial transport function, and thus became the gold standard for surgical treatment of AF. The original procedure underwent two modifications to become the Maze III procedure of today. Cox and colleagues [6] have reported excellent results, with a 1.2% mortality rate and 99.8% restoration of sinus rhythm. Other surgeons performing the Maze procedure have reported success rates ranging between 76% and 97% [7, 8]. Although shown to be highly effective, the Maze III procedure, even after the latest modifications, has been criticized for being a difficult and lengthy procedure, making it less ideal for combined procedures. Because of the invasive nature of the procedure and the bleeding risk, multiple attempts have been made to create faster and simpler procedures for curing AF. In 1998, Haissaguerre and colleagues [9] demonstrated that elimination of focal triggers by RF could cure AF. They as well as other investigators have shown that these trigger zones are mostly located around the left and right pulmonary veins, the free wall of both atria, and the ligament of Marshall. These contributions have led to the development of several modifications to the surgical management of AF using RF, cryoablation, or even bipolar cauterization techniques [10, 11]. In light of preliminary mapping studies indicating that the left-sided atrium is the source of the fibrillatory mechanism associated with valvular heart disease, these investigators suggested that surgical procedures addressing only the left atrium should be sufficient. Some groups have even used epicardial RF alone or combined with the endocardial approach [12]. The motivation behind these modifications was to simplify the overall operation. Most of these techniques focusing on a left-sided ablation procedure reported success rates ranging from 69% to 80% [13, 14]. Although the operative procedure was simplified, the success rate for sinus rhythm was less than that achieved with the Maze III procedure.

There have been recent reports of higher restoration of sinus rhythm with only a left-sided RF procedure. Pasic and colleagues [15] have recently published their modification of the Maze procedure. This is an RF Maze operation (Berlin modification) that is based on the principle of the left atrial part of the Maze III procedure combined with the method of isolation of the pulmonary veins. These investigators did not excise or exclude the LAA. The freedom from AF was 92% at 6 months postoperatively.

Isobe and colleagues [16] have recently reported their experience with a modification of the Maze III procedure in which they preserved both atrial appendages. By doing so they claim to improve atrial natriuretic peptide secretion, to retain atrial transport function, and to simplify the operation without decreasing its effectiveness against atrial fibrillation. They were able to restore sinus rhythm in 95.7% of patients. On the other hand, some researchers argue that LAA excision, even if not necessary to interrupt atrial macro reentry circuits, is important to avoid thrombus formation [6]. This is our view, as well.

Some proponents of the procedure involving the left-sided Maze only suggest that the procedure is less time consuming, that it eliminates the need for incisions in the right atrium, and that even if a patient develops atrial flutter after the operation, this problem can easily be managed by catheter ablation techniques [13, 14]. Although this may be true, a second procedure will increase the cost considerably; in addition, this option may not be available in all centers.

In an effort to reduce the number of incisions required for the Maze III procedure, Sie and colleagues [3, 17] have used SIRFMM procedure to create the majority of the required lesions. They reported freedom from AF of 98% ± 1.5% at 1 year. This rate dropped to 86% at 2 years and to 78% at 3 years. Although 83% of patients demonstrated right atrial transport, this rate was 77% on the left side at their last echocardiographic examination. Their series remain highly successful in terms of restoration of sinus rhythm and long-term results in comparison to other series using RF techniques. Khargi and associates [4] have compared the results of 60 patients undergoing mitral valve replacement (MVR) alone or MVR with the SIRFMM procedure, and concluded that at the end of 2 years, patients who underwent the SIRFMM procedure enjoyed a freedom from AF at a rate of 80% versus 20% in the MVR-alone group. We conducted a similar retrospective analysis and evaluated the data of 20 patients with chronic AF who had undergone a mitral valve procedure earlier. At the end of 1 month, only 1 patient was in sinus rhythm (5%). This was reported as 7% in a study published by Melo and associates [14]. The idea that some of these patients do convert to sinus rhythm irrespective of ablation, and that ablation may not be necessary, does not seem to be justified by the present data.

The saline-irrigated RF energy has some theoretical advantages over dry RF energy. The problem with the latter is the limitation of the depth that it can penetrate into the tissue [4, 17]. When using irrigated RF, the normal saline irrigation cools the surface temperature so that direct resistive heating is directed below the surface, resulting in a lesion of greater depth and in a higher chance of creating a transmural lesion [17]. Tissue injury due to excessive application of the cardioblate pen has been reported. This occurred in two cases in our series in which the injury could easily be repaired using 5-0 Prolene sutures. This can be kept to a minimum with experience. Three patients in our series were reopened for bleeding. All bleedings were associated with the LAA amputation site. In 1 patient, bleeding was due to partial disruption of the suture line. This complication occurred early in our experience when LAA amputation site was sutured before completion of the left-sided ablation. Because of the suspicion that such a complication may have been a result of damage to the suture line by RF heat waves, we changed our protocol so that amputation site was not sutured before the completion of left-sided RF ablation. As the LAA is a fragile tissue and as bleeding can still occur, another option is to ablate the LAA circumferentially within the left atrium, which was performed in 9 patients.

Whether a limited ablation procedure will restore sinus rhythm in the majority of patients with structural heart disease still remains to be investigated. Evidence collected so far suggests that the excellent results established by the Maze III procedure should not be compromised for the sake of simplifying the procedure.

Left atrial diameter or volume has been a concern for the success of the Maze procedure. It has been reported that patients with a left atrial diameter of more than 65 mm have lower conversion rates to sinus rhythm [13, 15, 18]. Our experience has also shown that patients with a very large atrium have a higher rate of reconversion to AF (although a statistical analysis was not performed), and perhaps a left atrial reduction procedure should be added to the operation.

Whatever technique is used, even with the Maze III procedure, an early AF rate of almost 35% is reported [6, 13]. This incidence ranged between 5.2% and 28.6% in our series. These early arrhythmias usually respond well to medical therapy and provide a solid basis for antiarrhythmic therapy after the operation. This early AF has been reported by other groups as well, and is explained by the late (3 to 6 months) healing process of the atrial lesions and by the inflammatory process associated with the procedure; and it may be for this reason that many researchers report higher success rates at 1 year [13, 15, 16].

Patients in both groups A and B had a 100% freedom from AF at the end of the operation, suggesting the efficacy of both approaches. Holter monitoring revealed a higher rate of atrial arrhythmias and of episodes of AF and flutter in group B (p < 0.05). In addition, during follow-up, more patients stayed in sinus rhythm in group A than in group B, although this is not statistically significant. For this reason, we preferred the biatrial Maze procedure during the later part of our experience to avoid the necessity for a second catheter ablation procedure for atrial flutter.

Limitations of the study
This is a preliminary report on our experience, and it has two major limitations. These are the relatively small number of patients in each group as well as the short-term follow-up. Nevertheless, we were able to demonstrate that the SIRFMM procedure is easy to perform and that it is safe and effective. Longer follow-up with a larger series will be necessary to determine which procedure (left-sided Maze, biatrial Maze, appendage-preserving operation, epicardial approach, etc) would be the choice in this group of patients. Until then, our current policy is to perform the biatrial SIRFMM procedure for patients with chronic AF who are undergoing concomitant cardiac surgery, because adding the right-sided ablation did not complicate the procedure and seemed to improve results in our series, despite the lack of statistical significance.


    References
 Top
 Abstract
 Introduction
 Material and method
 Results
 Comment
 References
 

  1. Feinberg W.M., Blackshear J.L., Laupacis A., Kronmal R., Hart R.G. Prevalence, age distribution and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995;155:469-473.[Abstract/Free Full Text]
  2. Cox J.L., Schuessler R.B., D’Agostino H.J., Jr, et al. The surgical treatment of atrial fibrillation: III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991;101:569-583.[Abstract]
  3. Sie H.T., Beukemam W.P., Ramdal Misier R., Elvan A., Ennema J.J., Wellens H.J. The radiofrequency modified Maze procedure. A less invasive surgical approach to atrial fibrillation during open heart surgery. Eur J Cardio-thorac Surg 2001;19:443-447.[Abstract/Free Full Text]
  4. Khargi K., Deneke T., Haardt H., et al. Saline-irrigated cooled tip radiofrequency ablation is an effective technique to perform the Maze procedure. Ann Thorac Surg 2001;72:1090-1095.
  5. Guiradon G.M. Surgical treatment of atrial fibrillation. Herz 1993;18:51-59.[Medline]
  6. Cox J.L., Ad N., Palazzo T., et al. Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 2000;12:15-19.[Medline]
  7. Kosakai Y. Treatment of atrial fibrillation using the Maze procedure: the Japanese experience. Semin Thorac Cardiovasc Surg 2000;12:44-52.[Medline]
  8. McCarthy P.M., Cosgrove D.M., III, Castle L.W., White R.D., Klein A.L. Combined treatment of mitral regurgitation and atrial fibrillation with valvuloplasty and the Maze procedure. Am J Cardiol 1993;71:483-486.[Medline]
  9. Haissaguerre M., Jais P., Shah D.C., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-666.[Abstract/Free Full Text]
  10. Lee J.W., Choo S.J., Kim K.I., et al. Atrial fibrillation surgery simplified with cryoablation to improve left atrial function. Ann Thorac Surg 2001;72:1479-1483.[Abstract/Free Full Text]
  11. Patwardhan A.M., Dave H.H., Tamhane A.A., et al. Intraoperative radiofrequency micro bipolar coagulation to replace incisions of Maze III procedure for correcting atrial fibrillation in patients with rheumatic valvular disease. Eur J Cardio-thorac Surg 1997;12:627-633.[Abstract]
  12. Benussi S., Pappone C., Nascimbene O.G., et al. A simple way to treat atrial fibrillation during mitral valve surgery. The epicardial radiofrequency approach. Eur J Cardio-thorac Surg 2000;17:524-529.[Abstract/Free Full Text]
  13. Williams R.M., Steward R.J., Bolling F.S., et al. Surgical treatment of atrial fibrillation using radiofrequency energy. Ann Thorac Surg 2001;71:1939-1943.[Abstract/Free Full Text]
  14. Melo J., Adrago P., Neves J., et al. Endocardial and epicardial radiofrequency ablation in the treatment of atrial fibrillation with a new intraoperative device. Eur J Cardio-thorac Surg 2000;18:182-186.[Abstract/Free Full Text]
  15. Pasic M., Bergs P., Muller P., et al. Intraoperative radiofrequency Maze ablation for atrial fibrillation. The Berlin Modification. Ann Thorac Surg 2001;72:1484-1490.[Abstract/Free Full Text]
  16. Isobe F., Kumora H., Ishikawa T., et al. : biatrial appendage preserving Maze procedure. Ann Thorac Surg 2001;72:1473-1478.[Abstract/Free Full Text]
  17. Sie H., Beukema W.P., Misier A.R., et al. Radiofrequency modified Maze in patients with atrial fibrillation undergoing concomitant cardiac surgery. J Thorac Cardiovasc Surg 2001;122:249-256.[Abstract/Free Full Text]
  18. Sueda T., Nahata H., Shikata H., et al. Simple left atrial procedure for chronic atrial fibrillation associated with mitral valve disease. Ann Thorac Surg 1996;62:1796.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
H. T. McElderry, D. C. McGiffin, V. J. Plumb, K. Nanthakumar, A. E. Epstein, T. Yamada, and G. N. Kay
Proarrhythmic Aspects of Atrial Fibrillation Surgery: Mechanisms of Postoperative Macroreentrant Tachycardias
Circulation, January 15, 2008; 117(2): 155 - 162.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
I. Bakir, F. P. Casselman, P. Brugada, P. Geelen, F. Wellens, I. Degrieck, F. Van Praet, Y. Vermeulen, R. De Geest, and H. Vanermen
Current Strategies in the Surgical Treatment of Atrial Fibrillation: Review of the Literature and Onze Lieve Vrouw Clinic's Strategy
Ann. Thorac. Surg., January 1, 2007; 83(1): 331 - 340.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Jahangiri, G. Weir, K. Mandal, I. Savelieva, and J. Camm
Current strategies in the management of atrial fibrillation.
Ann. Thorac. Surg., July 1, 2006; 82(1): 357 - 364.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. D. Barnett and N. Ad
Surgical ablation as treatment for the elimination of atrial fibrillation: A meta-analysis
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1029 - 1035.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Akpinar, I. Sanisoglu, M. Guden, E. Sagbas, B. Caynak, and Z. Bayramoglu
Combined Off-Pump Coronary Artery Bypass Grafting Surgery and Ablative Therapy for Atrial Fibrillation: Early and Mid-Term Results
Ann. Thorac. Surg., April 1, 2006; 81(4): 1332 - 1337.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. A.C. Abreu Filho, L. A.F. Lisboa, L. A.O. Dallan, G. S. Spina, M. Grinberg, M. Scanavacca, E. A. Sosa, J. A. F. Ramires, and S. A. Oliveira
Effectiveness of the Maze Procedure Using Cooled-Tip Radiofrequency Ablation in Patients With Permanent Atrial Fibrillation and Rheumatic Mitral Valve Disease
Circulation, August 30, 2005; 112(9_suppl): I-20 - I-25.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. E. Halkos, J. M. Craver, V. H. Thourani, F. Kerendi, J. D. Puskas, W. A. Cooper, and R. A. Guyton
Intraoperative Radiofrequency Ablation for the Treatment of Atrial Fibrillation During Concomitant Cardiac Surgery
Ann. Thorac. Surg., July 1, 2005; 80(1): 210 - 216.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
B-K. Lam, M. Boodhwani, J. P. Veinot, P. J. Hendry, and T. G. Mesana
Surgical treatment of atrial fibrillation with diathermy: an in vitro study
Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 456 - 461.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Golovchiner, A. Mazur, A. Kogan, B. Strasberg, Y. Shapira, M. Fridman, J. Kuzniec, B. A. Vidne, and E. Raanani
Atrial Flutter After Surgical Radiofrequency Ablation of the Left Atrium for Atrial Fibrillation
Ann. Thorac. Surg., January 1, 2005; 79(1): 108 - 112.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Laczkovics, K. Khargi, and T. Deneke
Esophageal perforation during left atrial radiofrequency ablation
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2119 - 2120.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. T Sie, W. P Beukema, A. Elvan, and A. R Ramdat Misier
New strategies in the surgical treatment of atrial fibrillation
Cardiovasc Res, June 1, 2003; 58(3): 501 - 509.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
I. Malik
JournalScan
Heart, January 1, 2003; 89(1): 119 - 120.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Güden, M.
Right arrow Articles by Bayindir, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Güden, M.
Right arrow Articles by Bayindir, O.
Related Collections
Right arrow Electrophysiology - arrhythmias


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS